Translate this page into:
Editorial
doi:
10.4103/2278-330X.142940
Chronic myeloid leukemia in children, do we have all the answers?
1
Department of Oncology, Division of Pediatric Oncology, Sir. Harkishandas Nurrottamdas Reliance Foundation Hospital, Mumbai, Maharashtra
*Corresponding author: to: Dr. Shweta Bansal. doc.shwetabansal@gmail.com
MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
References
- Millot F, Traore P, Guilhot J, Nelken B, Leblanc T, Leverger G, et al. Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia. Pediatrics 2005;116:140-3.
- Linga VG, Ganta RR, Kalpathi KI, Gundeti S, Rajappa SJ, Digumarti R, et al. Response to imatainib mesylate in childhood myeloid leukemia in chronic phase. South Asian J Cancer 2014 ;3:203-5.
- Bansal S, Prabhash K, Parikh P. Chronic myeloid leukemia data from India. Indian J Med Paediatr Oncol 2013;34:154-8.
- Millot F, Baruchel A, Guilhot J, Petit A, Leblanc T, Betrand Y, et al. Imatinib is efficient but has a negative impact on growth in children with previously untreated chronic myelogenous leukaemia (CML) in early chronic phase (CP): Results of the French national phase IV trial. Blood 2009;110:863. [Abstract].
- Suttorp M, Thiede C, Tauer JT, Roettgers S, Sedlacek P, Harbott J. Chronic myeloid leukemia in pediatrics - First results from study CML-PAED II. Blood 2009;114:145. [Abstract].